Concepedia

Publication | Open Access

No Detectable Resistance to Tenofovir Disoproxil Fumarate After 6 Years of Therapy in Patients With Chronic Hepatitis B

DOIFull Paper Access

225

Citations

25

References

2013

Year

Kathryn M. Kitrinos, Amoreena C. Corsa, Yang Liu, John F. Flaherty, Andrea Snow‐Lampart, Patrick Marcellin, Katyna Borroto–Esoda, Michael D. Miller
Hepatology

Abstract

TDF monotherapy maintains effective suppression of HBV DNA through 288 weeks of treatment with no evidence of TDF resistance.

References

YearCitations

Page 1